Home

Lincoln Pharmaceuticals PE Ratio

Image

Lincoln Pharmaceuticals Ltd

NSE: LINCOLN

PE

12.8

Last updated on: Aug 23, 2025

Key Highlights

  • The P/E Ratio of Lincoln Pharmaceuticals Ltd is 12.8 as of 23 Aug 15:17 PM .
  • The P/E Ratio of Lincoln Pharmaceuticals Ltd changed from 5.2 on March 2020 to 12.6 on March 2024 . This represents a CAGR of 19.36% over 5 years.
  • The Latest Trading Price of Lincoln Pharmaceuticals Ltd is ₹ 550.7 as of 22 Aug 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.1 to 39.8 in 5 years. This represents a CAGR of 13.53%.
  • The PE Ratio of Automobile industry is 21.5. The PE Ratio of Finance industry is 19.4. The PE Ratio of IT - Software industry is 26.8. The PE Ratio of Pharmaceuticals industry is 32.2. The PE Ratio of Retail industry is 109.0. The PE Ratio of Textiles industry is 53.8 in 2025.

Historical P/E Ratio of Lincoln Pharmaceuticals Ltd

No data available

Company Fundamentals for Lincoln Pharmaceuticals Ltd

Image

Lincoln Pharmaceuticals Ltd

NSE: LINCOLN

Share Price

₹ 550.7

1.25 (0.23%)

stock direction

Last updated on: Aug 22, 2025

Market Price of Lincoln Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Lincoln Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Aug 2025550.7
21 Aug 2025549.45
20 Aug 2025558.15
19 Aug 2025560.7
18 Aug 2025546.5
14 Aug 2025543.05
13 Aug 2025544.4
12 Aug 2025545.85
11 Aug 2025547.65
08 Aug 2025563.35

SWOT Analysis Of Lincoln Pharmaceuticals Ltd

Strength

3

che

Weakness

1

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Lincoln Pharmaceuticals Ltd

Asset Value vs Market Value of Lincoln Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Lincoln Pharmaceuticals Ltd1103
Sun Pharmaceutical Industries Ltd394187
Divis Laboratories Ltd163282
Cipla Ltd128619
Torrent Pharmaceuticals Ltd124706
Mankind Pharma Ltd107559

PE Ratio of Lincoln Pharmaceuticals Ltd Explained

1103

Market cap

86

Earnings

12.8X

PE Ratio

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Lincoln Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Lincoln Pharmaceuticals Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Lincoln Pharmaceuticals Ltd

No data available

* All values are in %

About Lincoln Pharmaceuticals Ltd

  • Lincoln Pharmaceuticals Limited, promoted by Mahendra G Patel, Rajnikant G Patel and Hasmukhbhai I Patel, as a Partnership Firm in January, 1979 to manufacture pharmaceutical formulations was converted into a Public Limited Company in Jan. '95.
  • All the assets and business of the erstwhile partnership were transferred to the Company.
  • The Company is engaged in the business of manufacturing and trading of pharmaceutical products.
  • The focused area includes anti-infective, respiratory system, gynecology, cardio & CNS, anti-diabetic, anti malaria, among others. The Company, incorporated in January, 1995, was carrying on its business by getting its products manufactured on loan licence basis from 1979 to 1982.
  • It then set up its own manufacturing facilities at Naroda, Gujarat for manufacturing tablets, capsules, liquid and powder syrups and, ointments.

Lincoln Pharmaceuticals Ltd News Hub

Lincoln Pharmaceuticals consolidated net profit rises 24.51% in the June 2024 quarter

Net profit of Lincoln Pharmaceuticals rose 24.51% to Rs 23.67 crore in the quarter ended June 2024 a

Read more

09 Aug 24

Lincoln Pharmaceuticals AGM scheduled

Lincoln Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will be held

Read more

03 Sept 24

Lincoln Pharmaceuticals announces board meeting date

Lincoln Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 14 November

Read more

07 Nov 24

Lincoln Pharmaceuticals to conduct AGM

Lincoln Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will be held

Read more

03 Sept 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Lincoln Pharmaceuticals Ltd

What is the current PE Ratio of Lincoln Pharmaceuticals Ltd?

The Current PE Ratio of Lincoln Pharmaceuticals Ltd is 12.77 as on 23 Aug 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 32.2 as on 23 Aug 2025.

What was the PE Ratio of Lincoln Pharmaceuticals Ltd last year?

The PE Ratio of Lincoln Pharmaceuticals Ltd was 9.3 last year, now the PE ratio is 12.77, showing a year-on-year growth of 37.3%.

What does the PE Ratio of Lincoln Pharmaceuticals Ltd indicate about its stock?

The PE Ratio of Lincoln Pharmaceuticals Ltd is 12.77. This ratio indicates that investors are willing to pay 12.77 times the earnings per share for each share of Lincoln Pharmaceuticals Ltd.

What is the PE Ratio Growth of Lincoln Pharmaceuticals Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Lincoln Pharmaceuticals Ltd grew by 37.3% whereas, the EPS ratio grew by 139.1.

How does the PE ratio of Lincoln Pharmaceuticals Ltd compare to industry peers?

The PE ratio of Lincoln Pharmaceuticals Ltd PE Ratio can indicate whether it is overvalued or undervalued compared to competitors in the same industry. A lower PE ratio may suggest an undervalued stock, while a higher PE ratio could indicate premium pricing.

Is a high PE ratio for Lincoln Pharmaceuticals Ltd PE Ratio good or bad?

A high PE ratio may indicate strong future growth expectations, but it can also suggest overvaluation. It is best to compare it with industry averages and historical trends of Lincoln Pharmaceuticals Ltd PE Ratio.

What factors influence the PE ratio of Lincoln Pharmaceuticals Ltd PE Ratio?

The PE ratio of Lincoln Pharmaceuticals Ltd PE Ratio is influenced by factors such as earnings growth, investor sentiment, macroeconomic conditions, and sector trends.

How often does the PE ratio of Lincoln Pharmaceuticals Ltd PE Ratio change?

The PE ratio changes as the share price or earnings of Lincoln Pharmaceuticals Ltd PE Ratio fluctuate, and it is updated whenever there is a significant movement in either of these factors.

Where can I find the latest PE ratio of Lincoln Pharmaceuticals Ltd PE Ratio?

You can check the latest PE ratio of Lincoln Pharmaceuticals Ltd PE Ratio on BlinkX Website above or any other stock market platforms, or at the company’s official website.

What is a good PE ratio for Lincoln Pharmaceuticals Ltd PE Ratio?

A "good" PE ratio depends on industry standards and market conditions. It is advisable to compare Lincoln Pharmaceuticals Ltd PE ratio with its historical average and competitors.

Can the PE ratio of Lincoln Pharmaceuticals Ltd PE Ratio predict future stock performance?

While the Lincoln Pharmaceuticals Ltd PE ratio is a useful indicator of valuation, it should be used alongside other financial metrics and market analysis to make informed investment decisions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions